These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32089543)

  • 1. PD-L1/L2 protein levels rapidly increase on monocytes via trogocytosis from tumor cells in classical Hodgkin lymphoma.
    Kawashima M; Carreras J; Higuchi H; Kotaki R; Hoshina T; Okuyama K; Suzuki N; Kakizaki M; Miyatake Y; Ando K; Nakayama M; Umezu S; Horie R; Higuchi Y; Katagiri K; Goyama S; Kitamura T; Chamoto K; Yano S; Nakamura N; Kotani A
    Leukemia; 2020 Sep; 34(9):2405-2417. PubMed ID: 32089543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL.
    Vari F; Arpon D; Keane C; Hertzberg MS; Talaulikar D; Jain S; Cui Q; Han E; Tobin J; Bird R; Cross D; Hernandez A; Gould C; Birch S; Gandhi MK
    Blood; 2018 Apr; 131(16):1809-1819. PubMed ID: 29449276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory functions of PD-L1 and PD-L2 in the regulation of anti-tumor immunity in murine tumor microenvironment.
    Umezu D; Okada N; Sakoda Y; Adachi K; Ojima T; Yamaue H; Eto M; Tamada K
    Cancer Immunol Immunother; 2019 Feb; 68(2):201-211. PubMed ID: 30357491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering Cholesterol's Role in PD-L2 Stability: A Distinct Regulatory Mechanism From PD-L1.
    Zhang Y; Xiao T; Wen M; Shen L; Du L; Wei S; Wu B; Yu Y; Wang S; OuYang B
    J Mol Biol; 2024 Apr; 436(8):168500. PubMed ID: 38401626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance.
    Schönrich G; Raftery MJ
    Front Cell Infect Microbiol; 2019; 9():207. PubMed ID: 31263684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10.
    Rodríguez-García M; Porichis F; de Jong OG; Levi K; Diefenbach TJ; Lifson JD; Freeman GJ; Walker BD; Kaufmann DE; Kavanagh DG
    J Leukoc Biol; 2011 Apr; 89(4):507-15. PubMed ID: 21097698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helminth-induced Ly6C
    Terrazas C; de Dios Ruiz-Rosado J; Amici SA; Jablonski KA; Martinez-Saucedo D; Webb LM; Cortado H; Robledo-Avila F; Oghumu S; Satoskar AR; Rodriguez-Sosa M; Terrazas LI; Guerau-de-Arellano M; Partida-Sánchez S
    Sci Rep; 2017 Jan; 7():40814. PubMed ID: 28094319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma.
    Stewart BJ; Fergie M; Young MD; Jones C; Sachdeva A; Blain A; Bacon CM; Rand V; Ferdinand JR; James KR; Mahbubani KT; Hook L; Jonas N; Coleman N; Saeb-Parsy K; Collin M; Clatworthy MR; Behjati S; Carey CD
    Blood; 2023 May; 141(19):2343-2358. PubMed ID: 36758207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the Spatial Dynamics of the CD4+ T Cell Spectrum in Classical Hodgkin Lymphoma.
    Menéndez V; Solórzano JL; García-Cosío M; Cereceda L; Díaz E; Estévez M; Roncador G; Vega Z; Montalbán C; Kulasinghe A; García JF
    Mod Pathol; 2024 Jun; 37(9):100551. PubMed ID: 38936478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of miR-669m inhibits erythroblast differentiation.
    Kotaki R; Kawashima M; Yamaguchi A; Suzuki N; Koyama-Nasu R; Ogiya D; Okuyama K; Yamamoto Y; Takamatsu M; Kurosaki N; Ando K; Murata A; Ohtsuka M; Nakagawa S; Katagiri K; Kotani A
    Sci Rep; 2020 Aug; 10(1):13554. PubMed ID: 32782283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma.
    Cader FZ; Hu X; Goh WL; Wienand K; Ouyang J; Mandato E; Redd R; Lawton LN; Chen PH; Weirather JL; Schackmann RCJ; Li B; Ma W; Armand P; Rodig SJ; Neuberg D; Liu XS; Shipp MA
    Nat Med; 2020 Sep; 26(9):1468-1479. PubMed ID: 32778827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of trogocytosis in immune surveillance of Hodgkin lymphoma.
    Zeng Q; Schwarz H
    Oncoimmunology; 2020 Jun; 9(1):1781334. PubMed ID: 32934884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exit from germinal center to become quiescent memory B cells depends on metabolic reprograming and provision of a survival signal.
    Inoue T; Shinnakasu R; Kawai C; Ise W; Kawakami E; Sax N; Oki T; Kitamura T; Yamashita K; Fukuyama H; Kurosaki T
    J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33045065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotyping of the PD-L1-positive cells in angioimmunoblastic T cell lymphoma and Hodgkin disease.
    Tiemann M; Samoilova V; Atiakshin D; Buchwalow I
    BMC Res Notes; 2020 Mar; 13(1):139. PubMed ID: 32143684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Evolving Knowledge on T and NK Cells in Classic Hodgkin Lymphoma: Insights into Novel Subsets Populating the Immune Microenvironment.
    Ferrarini I; Rigo A; Visco C; Krampera M; Vinante F
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33327433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
    Shimada K; Yamaguchi M; Atsuta Y; Matsue K; Sato K; Kusumoto S; Nagai H; Takizawa J; Fukuhara N; Nagafuji K; Miyazaki K; Ohtsuka E; Okamoto M; Sugita Y; Uchida T; Kayukawa S; Wake A; Ennishi D; Kondo Y; Izumi T; Kin Y; Tsukasaki K; Hashimoto D; Yuge M; Yanagisawa A; Kuwatsuka Y; Shimada S; Masaki Y; Niitsu N; Kiyoi H; Suzuki R; Tokunaga T; Nakamura S; Kinoshita T
    Lancet Oncol; 2020 Apr; 21(4):593-602. PubMed ID: 32171071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of trogocytosis and exosome-mediated transport in establishing and maintaining the tumor microenvironment in lymphoid malignancies.
    Kawashima M; Higuchi H; Kotani A
    J Clin Exp Hematop; 2021 Dec; 61(4):192-201. PubMed ID: 34193756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells-macrophages crosstalk and myeloid malignancy.
    Li K; Nie H; Jin R; Wu X
    Front Immunol; 2024; 15():1397005. PubMed ID: 38779660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-L1 immunohistochemistry assay optimization to provide more comprehensive pathological information in classic Hodgkin lymphoma.
    Shi Y; Mi L; Lai Y; Zhao M; Jia L; Du T; Song Y; Li X
    J Hematop; 2023 Mar; 16(1):7-16. PubMed ID: 38175373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trogocytosis of CAR molecule regulates CAR-T cell dysfunction and tumor antigen escape.
    Zhai Y; Du Y; Li G; Yu M; Hu H; Pan C; Wang D; Shi Z; Yan X; Li X; Jiang T; Zhang W
    Signal Transduct Target Ther; 2023 Dec; 8(1):457. PubMed ID: 38143263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.